Biguanide class drugs

8 results

  • Invokamet

    (canagliflozin and metformin hydrochloride)
    Janssen Pharmaceuticals, Inc.
    Usage: INVOKAMET and INVOKAMET XR are indicated as adjuncts to diet and exercise for improving glycemic control in adults and pediatric patients aged 10 and older with type 2 diabetes mellitus. Canagliflozin component reduces risks of major cardiovascular events and kidney disease in specific patient populations.

  • Janumet

    (SITAGLIPTIN and METFORMIN HYDROCHLORIDE)
    Merck Sharp & Dohme LLC
    Usage: JANUMET is indicated for improving glycemic control in adults with type 2 diabetes as an adjunct to diet and exercise. It should not be used in type 1 diabetes and has not been studied in patients with a history of pancreatitis.

  • Janumet

    (sitagliptin and metformin hydrochloride)
    Merck Sharp & Dohme LLC
    Usage: JANUMET XR is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. It is not for use in patients with type 1 diabetes or those with a history of pancreatitis.

  • Jentadueto

    (linagliptin and metformin hydrochloride)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    Usage: JENTADUETO is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is not recommended for patients with type 1 diabetes or a history of pancreatitis, as its effects in these populations are unclear.

  • Kombiglyze

    (SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE)
    AstraZeneca Pharmaceuticals LP
    Usage: KOMBIGLYZE XR is indicated for the management of type 2 diabetes mellitus in adults. It is not recommended for treating type 1 diabetes mellitus or diabetic ketoacidosis.

  • Segluromet

    (ertugliflozin and metformin hydrochloride)
    Merck Sharp & Dohme LLC
    Usage: SEGLUROMET® is indicated for improving glycemic control in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise. It is not recommended for use in patients with type 1 diabetes.

  • Synjardy

    (empagliflozin and metformin hydrochloride)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    Usage: SYNJARDY and SYNJARDY XR are indicated as adjuncts to diet and exercise to improve glycemic control in adults and pediatric patients (≥10 years) with type 2 diabetes mellitus. Empagliflozin also reduces the risk of cardiovascular death and heart failure hospitalization in adults with established cardiovascular disease.

  • Trijardy xr

    (empagliflozin, linagliptin, metformin hydrochloride)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    Usage: TRIJARDY XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Empagliflozin within the combination helps reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. Not for type 1 diabetes.